文献速递新生儿儿童呼吸儿童心血管与肾脏

早产儿Noonan综合征伴全身性静脉淋巴管畸形

Preterm Noonan syndrome with generalised venolymphatic malformation
RSS 订阅 · ADC Fetal and Neonatal

一例34周早产女婴因新发致病性PTPN11变异1型导致Noonan综合征,合并静脉导管缺如,表现为严重全身水肿、双侧乳糜胸和显著海蛇头。常规治疗(中链甘油三酯营养、糖皮质激素、奥曲肽和西罗莫司)未能改善,生后6周启用MEK1/2抑制剂曲美替尼后2周内水肿和海蛇头明显消退,呼吸改善,生后8周拔管。

要点

  • 早产Noonan综合征合并全身性静脉淋巴管畸形可表现为严重水肿、乳糜胸和海蛇头。
  • 常规治疗包括中链甘油三酯营养、糖皮质激素、奥曲肽和西罗莫司未能获得临床改善。
  • 针对PTPN11相关RAS/MAPK通路过度激活,生后6周启用曲美替尼后2周内水肿和海蛇头明显消退。

核心结论

  • 在PTPN11相关RAS/MAPK通路失调驱动的全身性静脉淋巴管畸形早产儿中,曲美替尼治疗后2周内水肿和海蛇头明显消退,呼吸显著改善。

研究设计与样本

  • 单例早产女婴病例报告,胎龄34周,因新发致病性PTPN11变异1型诊断Noonan综合征,合并静脉导管缺如。

主要发现

  • 患儿表现为严重全身水肿、双侧乳糜胸和显著海蛇头,出生后因呼吸功能不全立即插管,并因严重胸腔积液行双侧胸腔引流。
  • 磁共振血管成像显示弥漫性皮下和肺内淋巴管扩张,符合全身性静脉淋巴管畸形。
  • 常规管理包括中链甘油三酯营养、糖皮质激素、奥曲肽和西罗莫司未能实现临床改善。
  • 生后6周启用曲美替尼后2周内水肿和海蛇头明显消退,呼吸显著改善,生后8周拔管。
  • 除痤疮样粉刺外,未报告其他治疗相关不良事件。

关键数值与推荐

  • 曲美替尼为选择性MEK1/2抑制剂,于生后6周启用,靶向致病性MAPK过度激活。

临床怎么用

  • 对于PTPN11相关RAS/MAPK通路失调驱动的全身性静脉淋巴管畸形早产儿,若常规治疗无效,可考虑靶向MEK抑制治疗。

局限性

  • 本文为单例病例报告,证据级别有限,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A preterm female neonate born at 34 weeks’ gestation with Noonan syndrome caused by a de novo pathogenic PTPN11 variant 1 and ductus venosus agenesis presented with severe generalised oedema, bilateral chylothorax and prominent caput medusae. Postnatally, immediate intubation was required for respiratory insufficiency, followed by bilateral chest drains for severe pleural effusions. Magnetic resonance angiography demonstrated diffuse subcutaneous and intrapulmonary lymphangiectasia, consistent with a generalised venolymphatic malformation. Conventional management, including medium-chain triglyceride-based nutrition, corticosteroids, octreotide and sirolimus, failed to achieve clinical improvement. Given the underlying PTPN11 -associated RAS/MAPK pathway dysregulation, trametinib, a selective MEK1/2 inhibitor, 2 3 was initiated at 6 weeks after birth to target the pathogenic MAPK overactivation thought to drive the lymphatic disorder. Within 2 weeks, oedema and caput medusae regressed substantially, accompanied by marked respiratory improvement, allowing for extubation at 8 weeks after birth ( figure 1A,B ). Apart from acne comedonica, no treatment-related...

来源:ADC Fetal and Neonatal,查看原文。版权归原作者所有。

引用

  1. ADC Fetal and Neonatal:Preterm Noonan syndrome with generalised venolymphatic malformation

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。